{"hq_id":"hq-p-spe-000009","name":"Silicone Breast Implants (Textured and Smooth)","category":{"primary":"specialty","secondary":"","tags":[]},"product_tier":"SPE","overall_risk_level":"low","description":"BIA-ALCL (898+ cases, 33 deaths); silicone bleed into blood; platinum leachables Key materials: Breast Implant Chemistry: BIA-ALCL, Silicone Gel Bleed, and Platinum Catalyst Leachables.","synthesis":{"derived_risk_level":"moderate_to_high","synthesis_confidence":0.673,"synthesis_method":"compound_composition","context_used":"human_infant","context_source":"product_users","exposure_modifier":1.15,"vulnerability_escalated":true,"escalation_reason":"Infant exposure group","compounds_resolved":1,"compounds_total":1,"synthesis_date":"2026-05-09","synthesis_version":"1.2.0","methodology_note":"exposure_modifier and adjusted_magnitude are computed from ALETHEIA-calibrated heuristics (route × duration × frequency multipliers, clamped to [0.5, 1.4]). Multipliers are directionally informed by EPA Exposure Factors Handbook (2011) and CalEPA OEHHA but are not regulatory consensus. See /api/methodology for full disclosure."},"hazard_summary":{"sensitive_populations":"infants","overall_risk":"low","primary_concerns":["Overall risk level: low."],"exposure_routes":""},"exposure":{"routes":["dermal"],"contact_types":["dermal","internal_reproductive"],"users":["adult","infant"],"duration":"hours","frequency":"daily","scenarios":["Incidental mouthing or hand-to-mouth transfer by children"],"notes":"Exposure to Silicone Breast Implants (Textured and Smooth) occurs via dermal. Children and infants face higher exposure per body weight due to developing detoxification systems, higher surface-area-to-weight ratio, and behavioral factors (mouthing, crawling)."},"consumer_guidance":{"red_flags":[{"indicator":"Identified safety concern","meaning":"Overall risk level: low.","action":"Review safety data; follow use guidelines; consider alternatives"}],"green_flags":[{"indicator":"Third-party safety tested","meaning":"Independent laboratory verification of safety claims","verification":"Check for recognized certification marks and test reports"}],"what_to_ask":[{"question":"What safety testing has this product undergone?","why_it_matters":"Third-party testing provides independent verification of safety claims"}],"alternatives":[{"name":"Saline breast implants","notes":"If rupture occurs, body safely absorbs saline; easier detection of deflation"},{"name":"Fat grafting augmentation","notes":"Uses patient's own tissue; eliminates foreign body rejection and rupture concerns"}],"notes":null},"regulatory":{"applicable_regulations":[{"jurisdiction":"USA","regulation":"FDA 21 CFR Parts 800–898 (Medical Devices)","citation":null,"requirements":"Device classification (Class I/II/III). Biocompatibility testing per ISO 10993. Good Manufacturing Practice (GMP) under 21 CFR Part 820.","compliance_status":null,"effective_date":null,"enforcing_agency":null,"penalties":null,"source_ref":null},{"jurisdiction":"EU","regulation":"Medical Devices Regulation (EU) 2017/745 (MDR)","citation":null,"requirements":"CE marking. Clinical evaluation. Unique Device Identification (UDI). CMR/EDC substance restrictions unless justified by risk-benefit analysis.","compliance_status":null,"effective_date":null,"enforcing_agency":null,"penalties":null,"source_ref":null}],"certifications":[{"name":"ISO 10993","issuer":"ISO","standard":"ISO 10993 Biological Evaluation of Medical Devices","scope":"Biocompatibility testing — cytotoxicity, sensitization, irritation, systemic toxicity"},{"name":"FDA 510(k)/PMA","issuer":"FDA","standard":"21 CFR Parts 860-892","scope":"Medical device clearance/approval including material biocompatibility"}],"labeling":{"required_disclosures":[],"prop65_warning":{"required":null,"chemicals":[],"endpoint":null,"notes":null},"ghs_labeling":{"required":null,"signal_word":null,"pictograms":[],"hazard_statements":[],"notes":null},"hidden_ingredients":{"trade_secret_protected":null,"categories_hidden":[],"estimated_count":null,"known_concerns":null,"notes":null},"notes":null},"recalls":[],"regulatory_gap":null,"notes":null},"lifecycle":{"recyclable":false,"disposal_guidance":"Medical waste disposal; sharps containers; do not place in regular trash","hazardous_waste":true,"expected_lifespan":"disposable"},"formulation":{"form":"composite_material","key_ingredients":[{"hq_id":null,"name":"Primary component","role":"base_material","concentration_pct":"70-80"},{"hq_id":null,"name":"Secondary component","role":"additive","concentration_pct":"10-20"},{"hq_id":null,"name":"Filler or coating","role":"filler","concentration_pct":"5-10"}],"certifications":[]},"materials":{"common":[{"material_id":"hq-m-str-000094","material_name":"Breast Implant Chemistry: BIA-ALCL, Silicone Gel Bleed, and Platinum Catalyst Leachables","component":null,"prevalence":"common"}],"concerning":[{"material_id":"hq-m-str-000094","concern":"BIA-ALCL: rare T-cell lymphoma in pericapsular capsule; 898+ confirmed cases (FDA 2022), 33 deaths; risk concentrated in textured implants (Allergan Biocell: 83% of cases); Allergan internal data showed elevated signal ~2011; device not recalled until July 2019 (8-year delay between known signal and recall)","compounds_of_concern":[],"source_refs":[]},{"material_id":"hq-m-str-000094","concern":"Silicone gel bleed through intact shell: low-MW silicone permeates intact elastomer shell; detectable in blood, liver, spleen, lymph nodes of recipients with intact implants; no rupture required; bioaccumulation over decades","compounds_of_concern":[],"source_refs":[]},{"material_id":"hq-m-str-000094","concern":"Platinum catalyst leachables: residual Pt(0) in PDMS oxidizes in vivo to genotoxic Pt(II/IV); detectable in pericapsular tissue and blood; no FDA maximum established for implant platinum","compounds_of_concern":[],"source_refs":[]},{"material_id":"hq-m-str-000094","concern":"Post-market safety signal management: BIA-ALCL signal in Allergan internal database (MAUDE data) managed as voluntary adverse event reporting rather than triggering proactive safety investigation or recall; reclassification and action only after 8-year accumulation of cases","compounds_of_concern":[],"source_refs":[]},{"material_id":"hq-m-str-000094","concern":"Potential contaminant: Cyclic siloxanes (D4, D5, D6)","compounds_of_concern":["hq-c-org-000668"],"source_refs":[]}],"preferred":[]},"compound_composition":[{"hq_id":"hq-c-ino-000084","compound_name":"Platinum (and platinum-based catalysts)","role":"base","typical_concentration":null}],"identifiers":{"common_names":["silicone breast implants","silicone breast implant","textured and smooth"],"brands":["Allergan Biocell (recalled 2019)","Mentor MemoryGel","Sientra","saline alternatives"],"aliases":[],"manufacturer":null},"brand_examples":[{"brand":"Generic Mass-Market Brand A","manufacturer":"Consumer Products Corporation","market_position":"mass_market","notable":"Widely available mass-market option"},{"brand":"Generic Mass-Market Brand B","manufacturer":"Consumer Goods Ltd","market_position":"mass_market","notable":"Popular budget alternative"},{"brand":"Premium Brand A","manufacturer":"Premium Consumer Inc","market_position":"premium","notable":"Upscale premium positioning"},{"brand":"Professional Brand","manufacturer":"Professional Products Co","market_position":"professional","notable":"Professional/salon-grade option"},{"brand":"Specialty Eco-Brand","manufacturer":"Natural Products Ltd","market_position":"premium","notable":"Sustainable/natural product line"}],"brand_examples_disclaimer":"Representative branded products of this category. Concerning ingredients listed in materials.concerning[] apply to the category, not necessarily to every named brand. Specific formulations vary by SKU and may have changed since this record was written; consult the brand's current ingredient label before drawing brand-level conclusions.","sources":[{"id":"src_001","type":"regulatory","title":"FDA Black Box Warning: BIA-ALCL (2021); Allergan Biocell Recall (July 2019)","year":2019,"inherited_from":"hq-m-str-000094"},{"id":"src_002","type":"journal","title":"Allergan Biocell Textured Implant and BIA-ALCL: 898+ Cases, 33 Deaths; Internal Safety Signal 2011–2019 Gap","year":2022,"inherited_from":"hq-m-str-000094"},{"id":"src_003","type":"journal","title":"Silicone Gel Bleed Through Intact Breast Implant Shell: Detection in Blood, Liver, and Lymph Node","year":2020,"inherited_from":"hq-m-str-000094"},{"id":"src_004","type":"journal","title":"Platinum Detection in Pericapsular Tissue and Blood of Silicone Implant Recipients","year":2020,"inherited_from":"hq-m-str-000094"}],"meta":{"schema_version":"4.0.0","last_updated":"2026-03-25","timestamp":"2026-05-14T01:22:52.418Z"}}